Reverse Transcription Polymerase Chain Reaction (RT-PCR) Kits Market Report 2026

Reverse Transcription Polymerase Chain Reaction (RT-PCR) Kits Market Overview

• Reverse Transcription Polymerase Chain Reaction (RT-PCR) Kits market size has reached to $5.36 billion in 2025 • Expected to grow to $8.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.9% • Growth Driver: Rising Incidence Of Infectious Diseases Fueling The Growth Of The Market Due To Increasing Demand For Rapid And Accurate Disease Detection • Market Trend: Development Of High-Performance RT-qPCR Kits Accelerating Growth Through Enhanced Diagnostic Accuracy • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Reverse Transcription Polymerase Chain Reaction (RT-PCR) Kits Market?

Reverse transcription polymerase chain reaction (RT-PCR) kits are molecular diagnostic tools used to detect and measure RNA by converting it into complementary DNA (cDNA) and amplifying specific genetic sequences. Their primary use is the rapid and accurate detection of respiratory infections. The main types of reverse transcription polymerase chain reaction (RT-PCR) kits include one step reverse transcription polymerase chain reaction kits, two step reverse transcription polymerase chain reaction kits, digital reverse transcription polymerase chain reaction kits, and other types. One step reverse transcription polymerase chain reaction kits refer to integrated testing solutions that perform reverse transcription and polymerase chain reaction amplification in a single workflow for efficient RNA analysis. These kits are available in packaging types including assay kits, reagent kits, test panels, complete kits, and other packaging types and utilize technologies such as conventional polymerase chain reaction technologies, real time polymerase chain reaction technologies, next generation sequencing compatible technologies, and other technologies. They find application in gene expression analysis, infectious disease detection, genetic research, oncology studies, and others, serving end users including academic research institutions, diagnostic laboratories, pharmaceutical and biotechnology companies, contract research organizations, and others.

What Is The Reverse Transcription Polymerase Chain Reaction (RT-PCR) Kits Market Growth Forecast?

The reverse transcription polymerase chain reaction (RT-PCR) kits market size is expected to see strong growth in the next few years. It will grow to $8.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to growing demand for multiplex pathogen detection solutions, increasing adoption of digital PCR technologies, rising focus on personalized and precision medicine applications, expansion of decentralized and point of care molecular testing, advancing development of automated high throughput diagnostic platforms. Major trends in the forecast period include increasing adoption of multiplex RT-PCR assays for simultaneous pathogen detection, growing demand for rapid turnaround molecular diagnostic testing, rising development of high sensitivity and low detection limit RT-PCR kits, expansion of point of care and portable RT-PCR testing solutions, enhanced focus on automation and workflow simplification in molecular diagnostics.

Global Reverse Transcription Polymerase Chain Reaction (RT-PCR) Kits Market Segmentation

1) By Type: One Step Reverse Transcription Polymerase Chain Reaction Kits, Two Step Reverse Transcription Polymerase Chain Reaction Kits, Digital Reverse Transcription Polymerase Chain Reaction Kits, Other Types 2) By Packaging Type: Assay Kits, Reagent Kits, Test Panels, Complete Kits, Other Packaging Types 3) By Technology: Conventional Polymerase Chain Reaction Technologies, Real Time Polymerase Chain Reaction Technologies, Next Generation Sequencing Compatible Technologies, Other Technologies 4) By Application: Gene Expression Analysis, Infectious Disease Detection, Genetic Research, Oncology Studies, Other Applications 5) By End User: Academic Research Institutions, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users Subsegments: 1) By One Step Reverse Transcription Polymerase Chain Reaction Kits: Rapid Diagnostic Kits, Infectious Disease Detection Kits, Viral Load Testing Kits, Gene Expression Analysis Kits, Multiplex Detection Kits 2) By Two Step Reverse Transcription Polymerase Chain Reaction Kits: High Sensitivity Detection Kits, Complementary Deoxyribonucleic Acid Synthesis Kits, Messenger Ribonucleic Acid Quantification Kits, Transcriptome Analysis Kits, Research Application Kits 3) By Digital Reverse Transcription Polymerase Chain Reaction Kits: High Throughput Analysis Kits, Absolute Quantification Kits, Rare Mutation Detection Kits, Single Cell Analysis Kits, Precision Oncology Testing Kits 4) By Other Types: Veterinary Diagnostic Kits, Customized Reverse Transcription Polymerase Chain Reaction Kits, Portable Testing Kits, Automated Molecular Testing Kits, Point Of Care Diagnostic Kits

What Is The Driver Of The Reverse Transcription Polymerase Chain Reaction (RT-PCR) Kits Market?

The rising incidence of infectious diseases is expected to propel the growth of the reverse transcription polymerase chain reaction (RT-PCR) kits market going forward. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can invade the body and disrupt normal physiological functions. The rising incidence of infectious diseases is mainly due to increasing global population movement and urbanization, which accelerate the spread of viruses and bacterial infections across regions. Reverse transcription polymerase chain reaction (RT-PCR) kits are used in infectious diseases to detect and identify RNA-based pathogens, such as viruses, through rapid and accurate amplification of viral genetic material. For instance, in March 2025, according to the UK Health Security Agency, a UK-based agency responsible for all health security, tuberculosis (TB) cases rose by 11% in 2023 compared to 2022, while preliminary data for 2024 indicated an additional 13% increase, resulting in over 600 more reported TB diagnoses in 2024 than in 2023. Therefore, the rising incidence of infectious diseases is driving the growth of the reverse transcription polymerase chain reaction (RT-PCR) kits industry.

Key Players In The Global Reverse Transcription Polymerase Chain Reaction (RT-PCR) Kits Market

Major companies operating in the reverse transcription polymerase chain reaction (rt-pcr) kits market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Siemens Healthineers AG, Merck KGaA, Becton Dickinson and Company, Hologic Inc., Eurofins Scientific SE, bioMérieux SA, Agilent Technologies Inc., Revvity Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., LGC Biosearch Technologies, Luminex Corporation, GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, Seegene Inc., New England Biolabs Inc., Sansure Biotech Inc., Tata Medical and Diagnostics Limited, Molbio Diagnostics Private Limited, Zymo Research Corporation

Global Reverse Transcription Polymerase Chain Reaction (RT-PCR) Kits Market Trends and Insights

Major companies operating in the reverse transcription polymerase chain reaction (RT-PCR) kits market are focusing on developing advanced molecular diagnostic solutions, such as high-performance RT-qPCR kits, to improve testing accuracy, sensitivity, and workflow efficiency. High-performance RT-qPCR kits refer to advanced molecular testing solutions designed to deliver rapid, precise, and reliable RNA detection for research and diagnostic applications. For instance, in April 2026, Watchmaker Genomics, a US-based biotechnology company, launched Stellar RT-qPCR and qPCR Kits to support robust assay development and molecular testing workflows. The kits are designed to provide enhanced sensitivity, reproducibility, and inhibitor tolerance, helping researchers and diagnostic laboratories achieve accurate results in gene expression analysis and infectious disease detection.

What Are Latest Mergers And Acquisitions In The Reverse Transcription Polymerase Chain Reaction (RT-PCR) Kits Market?

In April 2026, QuidelOrtho Corporation, an US-based pure-play diagnostics company, acquired LEX Diagnostics Limited for $100million. Through this acquisition, QuidelOrtho strengthened its molecular diagnostics portfolio by gaining access to LEX Diagnostics’ rapid PCR technology platform, including the ultra-fast VELO system capable of delivering RT-PCR results within minutes. LEX Diagnostics is an UK-based molecular diagnostics company specializing in ultra-fast RT-PCR testing platforms for infectious disease detection.

Regional Outlook

North America was the largest region in the reverse transcription polymerase chain reaction (RT-PCR) kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Reverse Transcription Polymerase Chain Reaction (RT-PCR) Kits Market?

The reverse transcription polymerase chain reaction (RT-PCR) kits market includes revenues earned by entities by providing serivces such as diagnostic testing services, laboratory analysis services, infectious disease screening services, and molecular testing support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The reverse transcription polymerase chain reaction (RT-PCR) kits market also includes sales of RT-PCR assay kits, reagent kits, primers and probes, enzymes, nucleic acid extraction kits, control samples, and related molecular diagnostic consumables used for RNA detection and infectious disease testing. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Reverse Transcription Polymerase Chain Reaction (RT-PCR) Kits Market Report 2026?

The reverse transcription polymerase chain reaction (RT-PCR) kits market research report is one of a series of new reports from The Business Research Company that provides reverse transcription polymerase chain reaction (RT-PCR) kits market statistics, including reverse transcription polymerase chain reaction (RT-PCR) kits industry global market size, regional shares, competitors with a reverse transcription polymerase chain reaction (RT-PCR) kits market share, detailed reverse transcription polymerase chain reaction (RT-PCR) kits market segments, market trends and opportunities, and any further data you may need to thrive in the reverse transcription polymerase chain reaction (RT-PCR) kits industry. This reverse transcription polymerase chain reaction (RT-PCR) kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.